胆囊收缩素与疼痛：综述
Cholecystokinin and pain: a review.
作者信息
McRoberts J W
出版信息
Anesth Prog. 1986 Mar-Apr;33(2):87-90.
Abstract
The recent discovery that cholecystokinin (CCK) is present in the nervous system has prompted studies that have nearly proven its neurotransmitter status. Pain modulation appears to be a major effect of CCK and proglumide, its antagonist. CCK's inhibitory effect and proglumide's potentiating effect on opiate analgesia may have clinical application; proglumide's inhibitory effect on opiate tolerance may help in management of chronic pain. More research is required before the CCK/opiate interaction can be exploited on a large scale to relieve pain.
摘要
最近发现胆囊收缩素（CCK）存在于神经系统中，这促使了一些研究，这些研究几乎证实了它的神经递质地位。疼痛调节似乎是CCK及其拮抗剂丙谷胺的主要作用。CCK对阿片类镇痛的抑制作用以及丙谷胺的增强作用可能具有临床应用价值；丙谷胺对阿片类耐受性的抑制作用可能有助于慢性疼痛的管理。在大规模利用CCK/阿片类相互作用来缓解疼痛之前，还需要更多的研究。
相似文献
1
Cholecystokinin and pain: a review.胆囊收缩素与疼痛：综述
Anesth Prog. 1986 Mar-Apr;33(2):87-90.
2
Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
Anesth Analg. 1985 Aug;64(8):801-6.
3
Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
Brain Res. 1985 Feb 18;327(1-2):169-80. doi: 10.1016/0006-8993(85)91511-2.
4
Interaction of cholecystokinin and opioids in pain modulation.
Pain Headache. 1987;9:247-65.
5
Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates.胆囊收缩素拮抗剂可选择性增强内源性阿片类物质诱导的镇痛作用。
Brain Res. 1985 Feb 18;327(1-2):181-90. doi: 10.1016/0006-8993(85)91512-4.
6
Lack of interaction between cholecystokinin and opioid systems in the central control of breathing.胆囊收缩素与阿片系统在呼吸中枢控制中缺乏相互作用。
Rev Esp Fisiol. 1989;45 Suppl:185-90.
7
[Cholecystokinin octapeptide (CCK-8) antagonized analgesia mediated by mu and kappa opioid receptors].
Sheng Li Xue Bao. 1990 Jun;42(3):219-25.
8
Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.胆囊收缩素与内源性阿片肽：对疼痛、认知和情绪的交互影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1225-38. doi: 10.1016/j.pnpbp.2005.08.008. Epub 2005 Oct 20.
9
Proglumide exhibits delta opioid agonist properties.丙谷胺具有δ阿片受体激动剂特性。
Alcohol Drug Res. 1987;7(3):135-46.
10
The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.阿片类拮抗剂纳洛酮和胆囊收缩素拮抗剂丙谷胺对安慰剂镇痛的相反作用。
Pain. 1996 Mar;64(3):535-543. doi: 10.1016/0304-3959(95)00179-4.
引用本文的文献
1
Rubbing Salt in the Wound: Molecular Evolutionary Analysis of Pain-Related Genes Reveals the Pain Adaptation of Cetaceans in Seawater.往伤口上撒盐：疼痛相关基因的分子进化分析揭示了鲸类在海水中的疼痛适应性
Animals (Basel). 2022 Dec 16;12(24):3571. doi: 10.3390/ani12243571.
2
CCK2 receptors in chronic pain.慢性疼痛中的CCK2受体
Neurobiol Pain. 2022 May 5;11:100092. doi: 10.1016/j.ynpai.2022.100092. eCollection 2022 Jan-Jul.
3
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management.胆囊收缩素2型受体，疼痛管理的药理学靶点。
Pharmaceuticals (Basel). 2021 Nov 19;14(11):1185. doi: 10.3390/ph14111185.
4
Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges.多功能阿片类药物衍生杂合体在神经病理性疼痛中的应用：临床前证据、思路与挑战。
Molecules. 2020 Nov 25;25(23):5520. doi: 10.3390/molecules25235520.
本文引用的文献
1
Opiate vs non-opiate footshock induced analgesia (FSIA): descending and intraspinal components.
Brain Res. 1982 Aug 5;245(1):97-106. doi: 10.1016/0006-8993(82)90342-0.
2
Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat.大鼠中阿片类和非阿片类刺激产生镇痛作用的证据。
Brain Res. 1982 Jul 15;243(2):315-21. doi: 10.1016/0006-8993(82)90255-4.
3
Immunological and biological studies on cholecystokinin in rat brain.
Am J Physiol. 1980 Sep;239(3):E232-5. doi: 10.1152/ajpendo.1980.239.3.E232.
4
Involvement of spinal opioid systems in footshock-induced analgesia: antagonism by naloxone is possible only before induction of analgesia.
Brain Res. 1982 Jun 24;242(2):309-26. doi: 10.1016/0006-8993(82)90314-6.
5
Opioid and non-opioid mechanisms of footshock-induced analgesia: role of the spinal dorsolateral funiculus.足部电击诱导镇痛的阿片类和非阿片类机制：脊髓背外侧索的作用
Brain Res. 1983 May 9;267(1):139-44. doi: 10.1016/0006-8993(83)91047-8.
6
Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
Science. 1984 Apr 27;224(4647):395-6. doi: 10.1126/science.6546809.
7
Immunohistochemical demonstration of a CCK-like peptide in the nervous system of a marine annelid worm, Nereis diversicolor O.F. Müller.
Cell Tissue Res. 1982;227(2):401-11. doi: 10.1007/BF00210894.
8
Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.神经肽缩胆囊素作为阿片类镇痛拮抗剂的证据。
Science. 1983 Jan 21;219(4582):310-2. doi: 10.1126/science.6294831.
9
Caerulein and cholecystokinin suppress beta-endorphin-induced analgesia in the rat.蛙皮素和胆囊收缩素可抑制大鼠体内β-内啡肽诱导的镇痛作用。
Eur J Pharmacol. 1982 Jun 4;80(4):421-5. doi: 10.1016/0014-2999(82)90089-9.
10
Organization of endogenous opiate and nonopiate pain control systems.内源性阿片类和非阿片类疼痛控制系统的组织
Science. 1982 Jun 11;216(4551):1185-92. doi: 10.1126/science.6281891.
Zotero 插件